Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology.

  • Revenue in EUR (TTM)15.10bn
  • Net income in EUR-91.00m
  • Incorporated2006
  • Employees32.76k
  • Location
    Evonik Industries AGRellinghauser Strasse 111ESSEN 45128GermanyDEU
  • Phone+49 20117701
  • Fax+49 2 011773475
  • Websitehttps://corporate.evonik.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EVKX.N:GER since
announced
Transaction
value
Thai Peroxide Co LtdDeal completed15 Dec 202315 Dec 2023Deal completed14.05%--
Data delayed at least 15 minutes, as of Sep 23 2024 16:35 BST.

Institutional shareholders

11.01%Per cent of shares held by top holders
HolderShares% Held
BlackRock Investment Management LLCas of 19 Sep 20249.19m1.97%
The Vanguard Group, Inc.as of 04 Sep 20248.18m1.76%
Norges Bank Investment Managementas of 31 Dec 20236.94m1.49%
Capital Research & Management Co. (Global Investors)as of 30 Jun 20244.89m1.05%
BlackRock Fund Advisorsas of 05 Sep 20244.39m0.94%
DWS Investments (UK) Ltd.as of 05 Sep 20244.17m0.89%
BNP Paribas Asset Management Europe SASas of 30 Aug 20243.58m0.77%
Janus Henderson Investors UK Ltd.as of 30 Aug 20243.45m0.74%
Deka Investment GmbHas of 05 Sep 20243.31m0.71%
Magallanes Value Investors SA SGIICas of 30 Jun 20243.19m0.69%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.